Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
Donmez A, Aksu K, Celik HA, Keser G, Cagirgan S, Omay SB, Inal V, Aydin HH, Tombuloglu M, Doganavsargil E.
Donmez A, et al. Among authors: tombuloglu m.
Thromb Res. 2005;115(4):287-92. doi: 10.1016/j.thromres.2004.09.010.
Thromb Res. 2005.
PMID: 15668188